The insulin / IGF axis is critically important for controlling gene transcription in the podocyte.

This study demonstrates that the insulin/IGF1 signaling axis is essential for podocyte survival and function by dynamically regulating gene transcription through the control of spliceosome activity, as evidenced by severe kidney failure and widespread cell death in mice and cells lacking both receptors.

The Gist

The Big Picture: The Kidney's "Gatekeepers" Need a Manager

Imagine your kidneys as a high-tech water filtration plant. The most critical part of this plant is a tiny, intricate filter made of special cells called podocytes. Think of these podocytes as the "gatekeepers" or "security guards" of the filter. Their job is to let water and waste pass through while keeping valuable proteins (like albumin) inside your blood. If these gatekeepers get sick or die, the filter breaks, proteins leak out, and you get kidney disease.

For a long time, scientists knew that two specific "managers"—Insulin and IGF1 (a growth hormone)—talk to these gatekeepers to keep them healthy. But this study asked a big question: What happens if we fire both managers at the same time?

The Experiment: Firing the Managers

The researchers created two types of models to test this:

1. Mice: They genetically engineered mice so that their kidney gatekeepers lost the ability to receive signals from both Insulin and IGF1.
2. Lab Cells: They took kidney cells in a dish and used a molecular "scissors" (Cre recombinase) to cut out the instructions for these two receptors.

The Result: It was a disaster.

• In Mice: The kidneys started failing. The gatekeepers stopped working, the filter got clogged with scar tissue (glomerulosclerosis), and protein leaked into the urine. Some mice even died within a few months.
• In the Lab: When both managers were removed from the cells, more than half of the gatekeepers died within a week.

The Discovery: The "Editing Room" Breakdown

So, why did the gatekeepers die? The researchers dug deep into the cells' machinery and found the culprit: The Spliceosome.

The Analogy: The Movie Editor
Imagine your DNA is a raw movie script. It contains the story, but it also has a lot of "junk" scenes, outtakes, and errors (called introns) that need to be cut out before the movie can be released.

• The Spliceosome is the editing team. Its job is to read the script, cut out the junk, and stitch the good scenes (exons) together to make a perfect, final movie (mRNA) that the cell can use to build proteins.
• Insulin and IGF1 are the executive producers. They don't edit the movie themselves, but they pay the bills, supply the equipment, and tell the editing team how to work.

What went wrong?
When the researchers removed the "executive producers" (Insulin/IGF1 receptors), the "editing team" (the spliceosome) went on strike.

1. The Team Shrank: The cells stopped making enough editing tools.
2. The Movies Got Ruined: Without a proper editor, the cells started leaving the "junk scenes" (introns) in the final movies.
3. The Result: The cells tried to build proteins based on these messy, unfinished scripts. The resulting proteins were broken, useless, or toxic. It's like trying to build a car using a blueprint that still has the "Do Not Install" warnings and test notes included. The car falls apart.

The Evidence: A "Glitch" in the System

The researchers used advanced technology to prove this:

• The "Long-Read" Camera: They used a special camera (Long-read RNA sequencing) to look at the "movies" being made. They found that in the cells without the managers, about 18% of the movies had "junk" left in them (intron retention), compared to only 14% in healthy cells.
• The "Broken Scripts": Many of these messy scripts had "Stop" signs in the wrong places (premature termination codons), meaning the cell would stop building the protein halfway through, creating a useless fragment.
• The "Fibrosis" Connection: One specific "movie" that got messed up was for a protein called Fibronectin. In healthy adult kidneys, this protein is usually quiet. But in the sick cells, the editing team accidentally turned on a "scar tissue" version of this protein. This explains why the kidneys in the sick mice became scarred and stiff.

The Twist: It's Not Just One Manager

The researchers also tested what happens if you fire only the Insulin manager or only the IGF1 manager.

• The Finding: The editing team didn't collapse completely if you fired just one. They could still function, though not perfectly.
• The Conclusion: Insulin and IGF1 work together like a dual-engine system. If you lose one engine, the plane can still fly. But if you lose both, the plane crashes. The body relies on this redundancy to keep the "editing team" working correctly.

Why Does This Matter?

This study changes how we think about kidney disease.

1. New Cause of Failure: We used to think insulin problems in the kidney were just about sugar or energy. Now we know they are also about how the cells read their own genetic instructions.
2. The "Spliceosome" Link: This suggests that if we can find ways to help the "editing team" stay active even when the managers are missing, we might be able to save the kidney gatekeepers.
3. Future Hope: It opens the door for new treatments that don't just lower blood sugar, but specifically protect the kidney's ability to process its genetic code correctly.

In short: The kidney's gatekeepers need a dual-manager system (Insulin + IGF1) to keep their "editing team" (spliceosome) working. Without it, the genetic scripts get messy, the proteins break, and the kidney filter collapses.

Technical Summary

1. Problem Statement

Podocytes are terminally differentiated epithelial cells critical for maintaining the glomerular filtration barrier. Dysfunction leads to albuminuria and end-stage kidney disease (ESKD). While the insulin receptor (IR) and insulin-like growth factor 1 receptor (IGF1R) are known to be important for podocyte health, their individual roles are distinct (metabolism vs. growth/mitochondrial function), and their structural homology suggests potential redundancy.

• The Gap: Previous studies showed that global loss of either receptor is lethal, and tissue-specific single knockouts have variable outcomes. However, the consequences of the simultaneous loss of both IR and IGF1R specifically in podocytes, and the underlying molecular mechanisms driving podocyte failure in this context, were unknown.
• Hypothesis: The authors hypothesized that the combined loss of IR and IGF1R signaling would be physiologically detrimental and sought to elucidate the specific gene transcriptional and post-translational mechanisms involved.

2. Methodology

The study employed a multi-omics approach combining in vivo mouse models, in vitro cell culture, proteomics, phosphoproteomics, and long-read RNA sequencing.

• Animal Models:
  • Generated podDKD mice: Podocyte-specific double knockout of IR and IGF1R using Pod-Cre recombinase crossed with floxed IR and IGF1R mice.
  • Phenotyping included urinary albumin:creatinine ratio (uACR), PAS staining for glomerulosclerosis, Masson's trichrome for fibrosis, Transmission Electron Microscopy (TEM) for foot process width, and immunofluorescence for podocyte count (WT1).
• Cell Models:
  • Created conditionally immortalized podocyte cell lines (ciDKD, ciIRKD, ciIGF1RKD) from floxed mice.
  • Used lentiviral Cre recombinase to induce acute, near-total (>80%) receptor knockdown.
  • Assessed cell viability, signaling (pAKT, pMAPK), and response to the spliceosome inhibitor pladienolide B.
• Omics Analyses:
  • Proteomics: TMT-labeled LC-MS/MS to quantify total protein abundance in ciDKD vs. wild-type (WT) cells.
  • Phosphoproteomics: TMT-labeled LC-MS/MS to map insulin/IGF1-induced post-translational modifications (PTMs) on spliceosomal proteins.
  • Long-Read RNA Sequencing: Oxford Nanopore PromethION sequencing to analyze alternative splicing events (specifically intron retention) using FLAIR and IsoQuant tools.
• Validation: Western blotting, qPCR, and immunohistochemistry were used to validate proteomic and transcriptomic findings.

3. Key Contributions

• Novel Phenotype: Demonstrated that simultaneous loss of IR and IGF1R in podocytes causes severe renal failure, distinct from single receptor knockouts.
• Mechanistic Insight: Identified spliceosome dysfunction as the primary molecular mechanism linking hormonal signaling loss to podocyte death.
• Dynamic Regulation: Revealed that insulin and IGF1 signaling dynamically regulate the spliceosome via phosphorylation of spliceosomal proteins and associated kinases.
• Cell-Type Specificity: Showed that podocytes are uniquely sensitive to spliceosome inhibition compared to glomerular endothelial cells.

4. Key Results

A. In Vivo Phenotype (podDKD Mice)

• Renal Failure: By 24 weeks, podDKD mice developed severe albuminuria, glomerulosclerosis, and tubular protein casts.
• Mortality: Approximately 20% of mice died between 4 and 24 weeks.
• Structural Damage: TEM revealed significant foot process effacement (widening) and disruption of the filtration barrier.
• Podocyte Loss: Significant reduction in podocyte number (WT1 staining) was observed.
• Note: Systemic parameters (body weight, blood glucose) remained normal, indicating the phenotype is kidney-specific.

B. In Vitro Viability and Signaling

• Cell Death: Simultaneous knockdown (ciDKD) resulted in >50% cell death within 7 days, whereas single knockouts were less lethal.
• Signaling Suppression: Acute stimulation with insulin or IGF1 failed to activate AKT or MAPK pathways in ciDKD cells, confirming effective receptor loss.

C. Proteomic Findings: Spliceosome Downregulation

• Global Changes: Proteomics revealed 2,715 downregulated and 2,127 upregulated proteins.
• Key Pathway: The most significantly enriched downregulated pathway was the spliceosome and RNA processing.
• Validation: Levels of key spliceosome components (EIF4A, SF3B4, PTBP2) were significantly reduced in ciDKD cells and in the glomeruli of podDKD mice.
• Sensitivity: Treatment of WT podocytes with the spliceosome inhibitor pladienolide B caused dose-dependent cell death, whereas glomerular endothelial cells were resistant, highlighting podocyte-specific reliance on spliceosome function.

D. Transcriptomic Findings: Splicing Errors

• Intron Retention: Long-read RNA sequencing showed a significant increase in transcripts with intron retention (~18% in ciDKD vs. 14% in WT).
• Unproductive Transcripts: There was a marked increase in transcripts containing premature termination codons (PTC), leading to nonsense-mediated decay and loss of functional protein.
• Fibronectin Isoforms: Specific dysregulation of Fn1 splicing was observed, with an increase in the fibrosis-associated EDA/EDB isoforms, correlating with the fibrotic phenotype in mice.

E. Phosphoproteomics: Hormonal Control of Splicing

• PTM Mapping: Insulin and IGF1 stimulation induced rapid phosphorylation of 27 spliceosomal proteins (70 events).
• Kinase Involvement: The study identified that kinases known to phosphorylate splicing factors (e.g., CDK11, SRPK1, and PACSIN3/CK2) were modulated by insulin/IGF1 signaling.
• Redundancy: While some PTMs were receptor-specific, many required the presence of both receptors for full regulation, suggesting a complex compensatory network.

5. Significance

• Paradigm Shift: This study establishes that extrinsic hormonal signaling (Insulin/IGF1) is not just metabolic but is critical for the genetic control of gene transcription in terminally differentiated cells like podocytes.
• Spliceosomopathy in Kidney: It links the loss of metabolic receptors to a "spliceosomopathy" (defective splicing), a mechanism previously associated with cancer and neurodegeneration, but now identified as a driver of diabetic kidney disease pathology.
• Therapeutic Implications: The findings suggest that maintaining IR/IGF1R signaling is essential for preserving the spliceosome function and genomic integrity of podocytes. Conversely, it highlights that spliceosome dysfunction is a critical bottleneck in podocyte survival.
• Mechanistic Clarity: The study resolves the variable phenotype of previous models by showing that near-total receptor loss is required to trigger the catastrophic failure of RNA processing, leading to cell death and renal failure.

In conclusion, the paper demonstrates that the insulin/IGF axis controls podocyte health by regulating the assembly and function of the spliceosome. Loss of this signaling leads to widespread RNA processing errors, accumulation of unproductive transcripts, and ultimately, podocyte death and glomerulosclerosis.